Silver Book Fact

Initiating and continuing beta-blocker use in most first-time heart attack survivors for 20 years would result in 72,000 fewer coronary heart disease deaths, 62,000 fewer heart attacks, and 447,000 gained life-years. Additionally, it would save up to $18 million.

Phillips, Kathryn A., Michael G. Shlipak, Pamela Coxson, Paul A. Heidenreich, Myriam G. Hunink, Paula A. Goldman, Lawrence W. Williams, Milton C. Weinstein, and Lee Goldman. Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction. JAMA. 2000; 284(21): 2748-54. http://jama.ama-assn.org/cgi/content/abstract/284/21/2748

Reference

Title
Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction
Publication
JAMA
Publication Date
2000
Authors
Phillips, Kathryn A., Michael G. Shlipak, Pamela Coxson, Paul A. Heidenreich, Myriam G. Hunink, Paula A. Goldman, Lawrence W. Williams, Milton C. Weinstein, and Lee Goldman
Volume & Issue
Volume 284, Issue 21
Pages
2748-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Satisfaction rates of heart valve disease patients with their treatment
     
  • “Increasing life expectancy in western society is a result of two major success stories in the prevention and treatment of human disease. The first milestone was eliminating the scourge of…  
  • Antihypertensive treatment has generated a benefit-to-cost ratio of at least 6:1 (6:1 in women and 10:1 in men).  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states
     
  • Treatment for hypertension using antihypertensive therapy has generated a benefit-to-cost ratio of at least 6:1.